SE381467B - Forfarande for framstellning av azolderivat - Google Patents

Forfarande for framstellning av azolderivat

Info

Publication number
SE381467B
SE381467B SE7207357A SE735772A SE381467B SE 381467 B SE381467 B SE 381467B SE 7207357 A SE7207357 A SE 7207357A SE 735772 A SE735772 A SE 735772A SE 381467 B SE381467 B SE 381467B
Authority
SE
Sweden
Prior art keywords
producting
procedure
azole derivatives
azole
derivatives
Prior art date
Application number
SE7207357A
Other languages
English (en)
Swedish (sv)
Inventor
J Dahm
J Borck
A Wild
J W Hovy
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SE381467B publication Critical patent/SE381467B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7207357A 1971-06-11 1972-06-05 Forfarande for framstellning av azolderivat SE381467B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2129012A DE2129012A1 (de) 1971-06-11 1971-06-11 Azol-derivate

Publications (1)

Publication Number Publication Date
SE381467B true SE381467B (sv) 1975-12-08

Family

ID=5810494

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7207357A SE381467B (sv) 1971-06-11 1972-06-05 Forfarande for framstellning av azolderivat

Country Status (21)

Country Link
US (2) US3933840A (xx)
JP (1) JPS5728705B1 (xx)
AT (6) AT328440B (xx)
AU (1) AU462556B2 (xx)
BE (1) BE784682A (xx)
BR (1) BR7203714D0 (xx)
CA (1) CA1008863A (xx)
CH (6) CH590856A5 (xx)
CS (6) CS167984B2 (xx)
DD (1) DD97206A5 (xx)
DE (1) DE2129012A1 (xx)
ES (2) ES403741A1 (xx)
FR (1) FR2140632B1 (xx)
GB (1) GB1331408A (xx)
HU (1) HU166271B (xx)
IL (1) IL39528A (xx)
NL (1) NL7207784A (xx)
PL (1) PL79513B1 (xx)
RO (1) RO60483A (xx)
SE (1) SE381467B (xx)
ZA (1) ZA723502B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
US4089865A (en) * 1971-10-27 1978-05-16 Syntex (U.S.A.) Inc. Certain thiazole compounds
GB1507032A (en) * 1974-08-06 1978-04-12 Serono Lab 2-thiol-4,5-diphenyloxazole s-derivatives
DE2549998A1 (de) * 1975-11-07 1977-05-12 Merck Patent Gmbh Mittel zur hemmung der thrombozytenaggregation
IT1099996B (it) * 1978-10-17 1985-09-28 Anic Spa Derivati del 4,5-difenil-ossazolo 2-ammino o 2-tio sostituiti e procedimento per il loro ottenimento
DE3060330D1 (en) * 1979-04-06 1982-06-09 Bayer Ag Azolyloxy-acetamides, process for their preparation and their use as herbicides
DE2946524A1 (de) * 1979-11-17 1981-06-11 Bayer Ag, 5090 Leverkusen Azolyloxy-carbonsaeure-n-oxy-amide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
US4451471A (en) * 1981-03-18 1984-05-29 Ciba-Geigy Corporation Certain 2,4,5-tri-substituted thiazoles, pharmaceutical compositions containing same and methods of using same
DE3336846A1 (de) * 1983-10-11 1985-04-25 Bayer Ag, 5090 Leverkusen Neue 2-mercaptothiazolderivate, verfahren zu deren herstellung sowie die verwendung von 2-mercaptothiazolderivaten in arzneimitteln
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
GB8610432D0 (en) * 1986-04-29 1986-06-04 Akzo Nv Amino-thiazole & oxazole derivatives
USRE34242E (en) * 1986-04-29 1993-05-04 Akzo N.V. Amino-oxazole compounds having dopaminergic activity
DE3807232A1 (de) * 1988-03-05 1989-09-14 Bayer Ag Substituierte acrylsaeureester
JPH02145524A (ja) * 1988-11-29 1990-06-05 Katsumi Nagata 木酢液より得られる医薬品原料の製造方法
JP2785879B2 (ja) * 1989-05-31 1998-08-13 ジ・アップジョン・カンパニー 治療学的に有用な２―アミノテトラリン誘導体
US5545755A (en) * 1989-05-31 1996-08-13 The Upjohn Company Therapeutically useful 2-aminotetralin derivatives
NZ236474A (en) * 1989-12-20 1993-07-27 Bristol Myers Squibb Co 4,5-diphenyl-2-oxazole octanoic, nonanoic and decanoic acid and ester derivatives, preparation and pharmaceutical compositions thereof
US5274117A (en) * 1990-01-22 1993-12-28 Hoechst-Roussel Pharmaceuticals, Inc. Process for the enantioselective synthesis of intermediates used in the preparation of physostigmine
US5840915A (en) * 1990-01-22 1998-11-24 Hoechst Marion Roussel, Inc. Process for the enatioselective synthesis of intermediates used
FR2663331B1 (fr) * 1990-06-14 1994-05-06 Bellon Laboratoires Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
WO1996038418A1 (en) 1995-06-02 1996-12-05 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6515014B2 (en) 1995-06-02 2003-02-04 G. D. Searle & Co. Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6512121B2 (en) 1998-09-14 2003-01-28 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6677364B2 (en) 1998-04-20 2004-01-13 G.D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
WO2000015229A1 (en) 1998-09-17 2000-03-23 Bristol-Myers Squibb Company METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION
US7358254B2 (en) 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
US7390824B1 (en) 1999-09-07 2008-06-24 Bristol-Myers Squibb Company Method for treating diabetes employing an aP2 inhibitor and combination
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US7329401B2 (en) * 2002-04-15 2008-02-12 The Regents Of The University Of California Cyclooxygenase-2 selective agents useful as imaging probes and related methods
TW200505446A (en) * 2003-01-17 2005-02-16 Fuj Isawa Pharmaceutical Co Ltd Inhibitor of cox
WO2023143741A1 (de) * 2022-01-28 2023-08-03 Symrise Ag Neue kühlstoffe und zubereitungen, die diese enthalten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2513923A (en) * 1947-11-10 1950-07-04 Ilford Ltd Dyestuffs from s-(thiazolyl-2)-thioglycollic acid and method for preparing same
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate

Also Published As

Publication number Publication date
US4051250A (en) 1977-09-27
IL39528A0 (en) 1972-07-26
CS167986B2 (xx) 1976-05-28
AU4285072A (en) 1973-12-06
CS167984B2 (xx) 1976-05-28
ATA489572A (de) 1975-06-15
DD97206A5 (xx) 1973-04-20
CH584210A5 (xx) 1977-01-31
CS167987B2 (xx) 1976-05-28
ES439448A1 (es) 1977-03-01
RO60483A (xx) 1976-08-15
CH584701A5 (xx) 1977-02-15
CS167988B2 (xx) 1976-05-28
US3933840A (en) 1976-01-20
CH585213A5 (xx) 1977-02-28
ATA136774A (de) 1975-05-15
ATA136874A (de) 1975-05-15
AT323158B (de) 1975-06-25
AT328440B (de) 1976-03-25
ATA136574A (de) 1975-05-15
AT327889B (de) 1976-02-25
ZA723502B (en) 1973-03-28
CH584700A5 (xx) 1977-02-15
ES403741A1 (es) 1976-04-01
CS167985B2 (xx) 1976-05-28
BE784682A (fr) 1972-12-11
AU462556B2 (en) 1975-06-12
PL79513B1 (xx) 1975-06-30
FR2140632B1 (xx) 1976-01-23
DE2129012A1 (de) 1973-01-04
CA1008863A (en) 1977-04-19
CS167989B2 (xx) 1976-05-28
NL7207784A (xx) 1972-12-13
IL39528A (en) 1976-08-31
FR2140632A1 (xx) 1973-01-19
HU166271B (xx) 1975-02-28
BR7203714D0 (pt) 1973-11-01
AT327892B (de) 1976-02-25
CH584702A5 (xx) 1977-02-15
CH590856A5 (xx) 1977-08-31
GB1331408A (en) 1973-09-26
ATA136674A (de) 1975-05-15
JPS5728705B1 (xx) 1982-06-18
AT327891B (de) 1976-02-25
AT327890B (de) 1976-02-25

Similar Documents

Publication Publication Date Title
SE381467B (sv) Forfarande for framstellning av azolderivat
SE422325B (sv) Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
FI55194B (fi) Foerfarande foer framstaellning av 6-substituerade 4-amino-1,2-dihydro-1-hydroxi-2-iminopyrimidiner
SU474150A3 (ru) Способ получени производных окса-1-диаза-3,8-спиро-(4,5)-декана
RO76228A (ro) Procedeu pentru prepararea hidrazinei
BE791908A (fr) Derives du benzimidazole
FI56002B (fi) Foerfarande foer framstaellning av antimykotiska 5-(3-jodpropargyloxi0-pyrimidiner
SE417711B (sv) Forfarande for framstellning av 5-iminometyl-2-nitroimidazolderivat
SE395455B (sv) Forfarande for framstellning av 3-(fenyl-piperazinyl) etylindoliner
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE389105B (sv) Forfarande for framstellning av vissa angivna ketaziner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE409858B (sv) Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat
SE380528B (sv) Forfarande for framstellning av 2-klor-7-hydroxi-11-piperazinyldibensoxazepmderivat
BE778213A (fr) Derives acyles
SE7605364L (sv) Forfarande for framstellning av antracenderivat
SU438183A3 (ru) Способ получения производных эбурнамина
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE386676B (sv) Forfarande for framstellning av tropan-3-ol-derivat
SU437298A3 (ru) Способ получения производных оксадиазолона
SE387950B (sv) Forfarande for framstellning av diazaborinderivat
SE389335B (sv) Forfarande for framstellning av vissa angivna ketaziner.